Breaking

Trump names several new White House picks to work on AI, crypto and more: ‘America First Patriots’
China warns US to stop arming Taiwan after Biden approves $571M in military aid
Trump nominates Callista Gingrich as U.S. ambassador to Switzerland, announces other picks
Lac Carheil Expanded Footprint, Drilling Fully Permitted
GOP rep who hasn’t voted in months living in retirement facility: source
The Fed Is The New Waffle House
Fetterman: Those hoping Trump fails are ‘rooting against the nation’
Sen. Rand Paul pledges to get Trump’s cabinet picks approved ‘as quickly as possible’

Investing
Stock
Economy
Editor’s Pick
Latest News
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

By December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Lac Carheil Expanded Footprint, Drilling Fully Permitted

December 23, 2024

Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance Shakes Investors

December 22, 2024

Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence

December 22, 2024

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
Popular News

Latest Posts
Categories
- Economy (83)
- Editor's Pick (85)
- Investing (340)
- Latest News (444)
- Stock (20)
About Greencandlemarkets.com

Disclaimer: Greencandlemarkets.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Greencandlemarkets.com

Top

Type above and press Enter to search. Press Esc to cancel.